Maturation of immunoglobulin G avidity after inactive gE deleted bovine herpesvirus type 1 (BHV-1) marker vaccination

Viral Immunology

Volumn 21, Issue 1, 2008, Pages 3-11

  Özkul, Aykut ^a   Demir, Başak ^a   Karaoǧlu, Taner ^a   Alkan, Feray ^a   Dinger, Ender ^a   Öncel, Taner ^b   Burgu, Ibrahim ^a  

^a ANKARA UNIVERSITY   (Turkey)

^b PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; MARKER VACCINE; RISPOVAL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GEOMETRY; HERPES VIRUS INFECTION; INFECTIOUS BOVINE RHINOTRACHEITIS VIRUS; MATURATION; NONHUMAN; OPTICAL DENSITY; SEROLOGY; STATISTICAL SIGNIFICANCE; VACCINATION;

ANIMALS; ANTIBODIES, VIRAL; ANTIBODY AFFINITY; CATTLE; GENE DELETION; HERPESVIRUS 1, BOVINE; HERPESVIRUS VACCINES; IMMUNIZATION, SECONDARY; IMMUNOGLOBULIN G; INFECTIOUS BOVINE RHINOTRACHEITIS; VACCINES, INACTIVATED; VIRAL ENVELOPE PROTEINS;

ANIMALIA; BOVINAE; BOVINE HERPESVIRUS 1;

EID: 41349083194     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.2007.0067     Document Type: Article

References (43)

1. Akingbade D, Cohen BJ, and Brown DWG: Detection of low avidity immunoglobulin G in oral fluid samples: New approach for rubella diagnosis and surveillance. Clin Diag Lab Immunol 2003;10:189-190.
2. Awad M, Michael A, Soliman SM, Samir SS, and Daoud AM: Trials for preparation of inactivated sheep pox vaccine using binary ethyleneimine. Egypt J Immunol 2003;10:67-72.
3. Bachmann MF, Kalinke U, Althage A, et al.: The role of antibody concentration and avidity in antiviral protection. Science 1997;276:2024-2027.
4. Björkman C, Gondim LFP, Näslund K, Trees AJ, and McAllister MM: IgG avidity pattern in cattle after ingestion of Neospora caninum oocysts. Vet Parasitol 2005;128:195-200.
5. Bodeus M, Feyder S, and Goubau P: Avidity of IgG antibodies distinguishes primary from non-primary cytomegalovirus infection in pregnant women. Clin Diag Virol 1998;9:9-16.
6. Chowdhury SI: Construction and characterization of an attenuated bovine herpesvirus type 1 (BHV-1) recombinant virus. Vet Microbiol 1996;52:13-23.
7. Eggers M, Bäder U, and Enders G: Combination of microneutralization and avidity assays: Improved diagnosis of recent primary human cytomegalovirus infection in single serum sample of second trimester pregnancy. J Med Virol 2000;60:324-330.
8. Engels M, and Ackermann M: Pathogenesis of ruminant herpesvirus infections. Vet Microbiol 1996;53:3-15.
9. Gibbs EPJ, and Rweyemamu MM: Bovine herpesviruses. Part 1. Bovine herpesvirus 1. Vet Bull 1977;47:317-343.
10. Gulati U, Kumari K, Wu W, Keitel WA, and Air GM: Amount and avidity of serum antibodies against native glycoproteins and denatured virus after repeated influenza whole virus vaccination. Vaccine 2005;23:1414-1425.
11. Gutierrez J, Rodriguez M, Maroto MC, Piedrola G, and Peiron J: Behaviour of IgG antibody avidity for the antigen and of IgA antibody in active cytomegalovirus, Epstein-Barr virus, Herpes Simplex virus and Human Herpesvirus 6 infections. Adaptation of a commercial test. J Infect 1997;35:25-30.
12. Hedman K, Hietala J, Tiilikainen A, et al.: Maturation of immunoglobulin G avidity after rubella vaccination studied by an enzyme linked immunosorbent assay (avidity-ELISA) and by haemolysis typing. J Med Virol 1989;27:293-298.
13. Hedman K, Lappalainen M, Söderlund M, and Hedman L: Avidity of IgG in serodiagnosis of infectious diseases. Rev Med Microbiol 1993;4:123-129.
14. Hunter RL: Overview of vaccine adjuvants: Present and future. Vaccine 2002;20:7-12.
15. Inouye S, Hasegawa A, Matsuno S, and Katow S: Changes in antibody avidity after virus infections: Detection by an immunusorbent assay in which a mild protein-denaturing agent is employed. J Clin Microbiol 1984;20:525-529.
16. Jones C: Alphaherpesvirus latency: Its role in disease and survival of the virus in nature. Adv Virus Res 1998;51:81-133.
17. Kaashoek MJ, Moerman A, Madic J, Weerdmeester K, Maris-Veldhuis M. Rijsewijk FA, and Van Oirschot JT: An inactivated vaccine based on a glycoprotein E-negative strain of bovine herpesvirus 1 induces protective immunity and allows serological differentiation. Vaccine 1995;13:342-346.
18. Kaashoek MJ, Moerman A, Madic J, Rijsewijk FAM, Quak J, Gielkens ALJ, and Van Oirschot JT: Conventionally attenuated glycoprotein E-negative strain of bovine herpesvirus type 1 is an efficacious and safe vaccine. Vaccine 1994;21:439-444.
19. Kaashoek MJ, Straver PH, Van Rooij EMA, and Van Oirschot JT: Virulence, immunogenicity and reactivation of seven bovine herpesvirus 1. 1. Strains: Clinical and virological aspects. Vet Rec 1996;139:416-421.
20. Kahrs RF: Infectious bovine rhinotracheitis: A review and update. J Am Vet Med Assoc 1977;171:1055-1064.
21. Longworh E, Borrow R, Goldblatt D, et al.: Avidity maturation following vaccination with a meningococcal recombinant hexavalent PorA OMV vaccine in UK infants. Vaccine 2002;20:2592-2596.
22. Marshall BC, and Adler SP: Avidity maturation following immunization with two human cytomegalovirus (CMV) vaccines: A live attenuated vaccine (Towne) and a recombinant glycoprotein vaccine (gB/MF59). Viral Immunol 2003;16:492-500.
23. Nedeljkovic J, Jovanovic T, and Oker-Blom C: Maturation of IgG avidity to individual rubella virus structural proteins. J Clin Virol 2001;22:47-54.
24. Nossal GJV: The molecular and cellular basis of affinity maturation in antibody response. Cell 1992;68:1-2.
25. Ott G, Barchfield GL, Chernoff D, Radhakrishnan R, Van Hoogevest P, and Van Nest G: Design and evaluation of a safe and potent adjuvant for human vaccine. In: Vaccine Design, The Subunit and Adjuvant Approach. (Powell MF, and Newman MJ, eds.). Plenum Press, New York, 1995, pp. 227-296.
26. Pannuti CS, Morello RJ, Moraes JC, Curti SP, Afonso AMS, Camargo MCC, and Souza VAUF: Identification of primary and secondary measles vaccine failures by measurement of immunoglobulin G avidity in measles cases during the 1997 Sao Paulo epidemic. Clin Diag Lab Immunol 2004;11:119-122.
27. Roizman B, Desrosiers RC, Fleckenstein B, Lopez C, Minson AC, and Studdert MJ: The family herpesviridae: An update. Arch Virol 1992;123:425-449.
28. Roque-Afonso AM, Grangeot-Keros L, Roquebert B, Desbois D, Poveda JD, Mackiewicz V, and Dussaix E: Diagnostic relevance of immunoglobulin G avidity for hepatitis A virus. J Clin Microbiol 2004;42:5121-5124.
29. Rousseau S, and Hedman K: Rubella infection and reinfection distinguish by avidity of IgG. Lancet 1988;14:1108-1109.
30. Sanz-Moreno JC, Limia-Sanchez A, Garcia-Comas L, Mosquera-Gutierrez MM, Echevarria-Mayo JE, Castellanos-Nadal A, and Ory-Manchon F: Detection of secondary mumps vaccine failure by means of avidity testing for specific immunoglobulin G. Vaccine 2005;23:4921-4925.
31. Scahaw EU: Report on BHV-1 marker vaccines and the accompanying diagnostic tests. Available at http://europa.eu.int/comm/food/fs/sc/scah/out49- en.pdf, 2000.
32. Schwyzer M, and Ackermann M: Molecular virology of ruminant herpesviruses. Vet Microbiol 1996;53:17-29.
33. Snowdon WA: The IBR-IPV virus: Reaction to infection and intermittent recovery of virus from experimentally infected cattle. Aust Vet J 1965;41:135-142.
34. Souza S, Bonon SHA, Costa SCB, and Rossi CL: Evaluation of an in-house specific immunoglobulin G (IgG) avidity ELISA for distinguishing recent primary from long-term human cytomegalovirus (HCMV) infection. Rev Inst Med Trop São Paulo 2003;45:323-326.
35. Souza VA, Pannuti CS, Sumita LM, and Andrade HF: Enzyme-linked immunosorbent assay-IgG antibody avidity test for single sample serologic evaluation of measles vaccines. J Med Virol 1997;52:275-279.
36. Steiner LA, and Eisen HN: Sequential changes in the relative affinity of antibodies synthesized during the immune response. J Exp Med 1967;126:1161-1183.
37. Studdert MJ, Baker AV, and Savan M: Infectious pustular vulvovaginitis virus infection of bulls. Am J Vet Res 1964;25:303-314.
38. Thiery E, Saliki J, Bublot M, and Pastoret PP: Reactivation of infectious bovine rhinotracheitis virus by transport. Comp Immunol Microbiol Infect Dis 1987;10:59-63.
39. Thomas HIJ, and Morgan-Capner P: The use of antibody avidity measurements for the diagnosis of rubella. Rev Med Virol 1991;1:41-50.
40. Tuokko H: Detection of acute measles infections by indirect and u-capture enzyme immunoassays for immunoglobulin M antibodies and measles immunoglobulin G antibody avidity enzyme immunoassay. J Med Virol 1995;45:306-311.
41. Van Oirschot JT: Bovine viral vaccines, diagnostics, and eradication: Past, present, and future. Adv Vet Med 1999;41:197-216.
42. Yan SS, and Fedorko DP: Recent advances in laboratory diagnosis of human cytomegalovirus infection. Clin Appl Immunol Rev 2002;2:155-167.
43. Yates WDG: A review of infectious bovine rhinotracheitis, shipping fever pneumonia and viral-bacterial synergism in respiratory disease of cattle. Can J Comp Med 1982;46:225-263.